木瓜直播

Charles Bankhead

Charles Bankhead

Authors >

Charles Bankhead

Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. His career spans more than 30 years, including a decade with Medical World News, a leading medical trade magazine of its time. He had a long and successful freelance career before joining 木瓜直播 in 2007. Charles graduated with honors from Texas Tech University, receiving a BA in journalism, and completed a master's degree in mass communication, with specialization in health communication, also at Texas Tech.

Connect:

email image

Latest from Charles Bankhead

SNO over a photo of George R. Brown Convention Center in Houston, TX.

TRK Inhibitor Active in Treatment-Refractory Glioblastoma

Also from SNO: Encouraging early results with ATM pathway inhibition, sonodynamic therapy

SNO over a photo of George R. Brown Convention Center in Houston, TX.

Hit and Miss for CDK4/6 Inhibitor in Recurrent Brain Cancer

Abemaciclib active in previously treated meningioma, fails to impress in glioblastoma combination

SNO over a photo of George R. Brown Convention Center in Houston, TX.

Preoperative Embolization Linked to Relapse-Free Survival in Meningioma

Significant impact on RFS with subtotal resection, and molecular analysis suggests hypoxic effect

SNO over a photo of George R. Brown Convention Center in Houston, TX.

Early Promise for PI3K Inhibitor in Brain Metastases

Also from SNO: TTFields boosts PFS in glioblastoma, proton therapy for leptomeningeal disease

SNO over a photo of George R. Brown Convention Center in Houston, TX.

IDH Inhibitor Activity in Brain Cancer Persists With Longer Follow-Up

Two-fold increase in PFS with postoperative ivosidenib holds up in placebo-controlled trial

SNO over a photo of George R. Brown Convention Center in Houston, TX.

Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy

Meta-analysis shows better PFS, OS with RT-first approach, but issue requires more study

Onco Break over a computer rendering of a cancer cell.

Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?

News, features, and commentary about cancer-related issues

A photo of a woman receiving chemotherapy.

Small Benefit, Persistent Toxic Risk With Adjuvant Anthracycline in Breast Cancer

Time for "long goodbye" to the "burning red devil," say editorialists

FDA APPROVED revumenib (Revuforj) over a computer rendering of leukemia cells.

FDA Approves First Menin Inhibitor for Acute Leukemia

Complete responses in 21% of patients treated with single-agent revumenib

A close up photo of a neurofibroma.

MEK Inhibitor Scores Big Win in Adults, Children With Neurofibromatosis Type 1

More than 40% of adults, half of children met response criteria, majority of responses durable

1

鈥�